Year: 2025

CALGARY, Alberta, March 12, 2025 (GLOBE NEWSWIRE) — Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) announces fourth quarter and year-end results for the period ended December 31, 2024. Fourth Quarter 2024 Highlights$77 million in revenue; $61 million in funds from operations ($0.40/share)(1)(3); $41 million in dividends paid ($0.27/share)(2); 9,878 bbls/d of total liquids production, a 5% increase from last quarter with approximately half from organic growth driven mainly from Canadian heavy oil, and the balance from the December 2024 Acquisition (detailed below); 15,306 boe/d of total production, with a record 65% weighting to oil and natural gas liquids (NGLs); Gross drilling of 288 wells, up 4% from last quarter; $53.80/boe average realized price ($65.48/boe in the U.S. and $46.53/boe in Canada);41% pricing...

SANTA PAULA, Calif., March 12, 2025 (GLOBE NEWSWIRE) — Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global avocado industry leader and provider of value-added fresh food, today reported its financial results for the fiscal first quarter ended January 31, 2025. First Quarter Financial OverviewTotal net sales of $154.4 million, a 21.0% increase from the prior year quarter.Fresh1 segment sales increased $26.8 million, or 23.7%, from the prior year quarter. Prepared segment sales remained essentially flat from the prior year quarter.Gross profit of $15.7 million, a 46.2% increase from the prior year quarter.Fresh segment gross profit of $12.1 million, an 88.8% increase from the prior year quarter. Prepared segment gross profit of $3.6 million, a 17.1% decrease from the prior year quarter.Selling, general, and administrative...

Revenue In Line With Expectations; Continued Progress to Enhance Profitability and Drive Margin Expansion VIENNA, Va., March 12, 2025 (GLOBE NEWSWIRE) — Urgent.ly Inc. (Nasdaq: ULY) (“Urgently”), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, today reported financial results for the fourth quarter and full-year ended December 31, 2024. “I am pleased with our significant accomplishments in 2024, as we continued to make strong progress in executing against our strategic initiatives to achieve profitability, operational efficiencies and disciplined expense management. For the year, we delivered revenue in line with our expectations, gross profit margin improvement of 160 basis points, a GAAP operating loss improvement of 41%, and non-GAAP operating loss improvement of 18%. In addition,...

Full Year 2024 results in line with guidance with Commercial Channel revenue up 17% Strong International OA Pain Management and greater than 40% sequential growth of Integrity™ Implant System drive Commercial Channel growth and 2024 results Key Regulatory and Clinical milestones achieved for Hyalofast®, Cingal®, and Integrity Strategic Sale of Parcus Medical complete; resources refocused on programs positioned to generate significantly higher returns BEDFORD, Mass., March 12, 2025 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (Nasdaq: ANIK), a global leader in the Osteoarthritis (“OA”) Pain Management and Regenerative Solutions space focused on early intervention orthopedics, today announced financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter and Full Year 2024 Results...

Successfully Completed Lab and Field Demonstrations Validating Effectiveness of NextNav’s 5G PRS-based PNT solution NOI Issued by FCC Chairman Carr Demonstrates Commitment to GPS Complement and Backup RESTON, Va., March 12, 2025 (GLOBE NEWSWIRE) — NextNav Inc. (NASDAQ: NN) a leader in next generation positioning, navigation, and timing (PNT) and 3D geolocation, today reported financial results for NextNav’s fourth quarter and full year ended December 31, 2024. Mariam Sorond, NextNav CEO said, “2024 was a pivotal year for NextNav as we established a strong foundation to advance our vision for a terrestrial complement and backup to GPS. We made significant progress through our regulatory efforts and our engagement in engineer-to-engineer dialogue with key stakeholders. As we enter 2025, we are eager to continue working with...

Record full year 2024 net sales of $25.2 million increased 57% over $16.0 million for the full year 2023 driven by 85% annual growth of Rx gammaCoreTM in the United States Department of Veteran Affairs and United States Department of Defense (VA) and 174% increase in TruvagaTM sales Company to host a conference call and webcast today, March 12, 2025 at 5:30pm EDT ROCKAWAY, N.J., March 12, 2025 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine Company and wellness company, today announced fourth quarter and full year 2024 financial results. Recent HighlightsReported record full year of 2024 revenue of $25.2 million, an increase of approximately 57% over full year of 2023 Net loss of $11.9 million for the full year ended December 31, 2024,...

Fourth Quarter Net Product Sales $29.6 Million, Cash Flow from Operations of $11.5 Million Full Year Net Product Sales $120.8 Million, Rolvedon Sales Exceed $60.0 Million Full Year Cash Flow from Operations of $26.4 Million, Cash and Investments Increases to $100.1 Million LAKE FOREST, Ill., March 12, 2025 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today reported financial results for the fourth quarter and full year ended December 31, 2024. Said Brendan O’Grady, Chief Executive Officer, “In line with our strategy for Assertio’s long-term growth, 2024 was a year of stabilization as we transitioned to Rolvedon as our primary asset. We enhanced our leadership team and board with additional expertise in legal, commercial, and strategy areas, optimized our cost structure, and strengthened...

Outlines Turnaround Plan and Long-Term Financial Targets Provides 2025 Financial Guidance   RICHARDSON, Texas, March 12, 2025 (GLOBE NEWSWIRE) — Fossil Group, Inc. (NASDAQ: FOSL) today announced financial results for the fourth quarter and fiscal year ended December 28, 2024. In a separate press release today, the Company also announced the appointment of Randy Greben as Chief Financial Officer, effective March 17, 2025. Fourth Quarter SummaryFourth quarter worldwide net sales were $342 million, down 19% on a reported basis and 18% in constant currency, with sales declines across all regions and all channels. The results included 600 basis points of negative impact related to the Company’s strategic actions to exit the smartwatch category and optimize its retail store portfolio.Fourth quarter gross margin expanded 630 basis...

PENNSAUKEN, N.J., March 12, 2025 (GLOBE NEWSWIRE) — RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through the deployment of advanced engineering, specialty health care, and information technology services, today announced financial results for the thirteen and fifty-two weeks ended December 28, 2024. RCM Technologies reported revenue of $76.9 million for the thirteen weeks ended December 28, 2024 (the current quarter), an increase of 8.3% compared to $71.0 million for the thirteen weeks ended December 30, 2023 (the comparable prior quarter). Gross profit was $21.6 million for the current quarter and the comparable prior quarter.  The Company experienced GAAP net income of $2.9 million, or $0.37 per diluted share, for the current quarter...

Delivers fourth quarter and full year net sales of $83.5 million and $334.3 million LONG BEACH, Calif., March 12, 2025 (GLOBE NEWSWIRE) — The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth”), home to flagship brand Hydrafacial, today announced financial results for the fourth quarter ended December 31, 2024 (“Q4 2024”). “In Q4 2024, we continued to strengthen our financial position, exceeding the high end of our guidance for both net sales and adjusted EBITDA,” said CEO Marla Beck. “We increased consumable sales, expanded our gross margins and continued to reduce our operating expenses, delivering $9 million of adjusted EBITDA in the quarter. We now have over 34,000 global delivery systems serving our large provider base.” “In 2025, we are focused on deepening partnerships, accelerating science-backed innovations, including...